174
Views
1
CrossRef citations to date
0
Altmetric
Cornea, Conjunctiva and Eyelids

The Impact of Post-Tear Collection Storage on Tear Film Substance P Concentration

ORCID Icon, ORCID Icon, & ORCID Icon
Pages 1116-1120 | Received 20 Feb 2022, Accepted 13 Apr 2022, Published online: 29 Apr 2022
 

Abstract

Purpose

Substance P is a sensory neuropeptide increasingly used as a biomarker for ocular and systemic neuropathic conditions. Due to the limited studies on tear storage conditions compared to other bodily fluids including blood and urine, the aim of this study was to investigate whether different storage durations at 4 °C can impact on substance P concentrations prior to storage at −80 °C. This is important to assess potential practical limitations in the handling and storage of tear fluid essential.

Methods

Tears were collected and pooled from both eyes of 31 healthy participants using the flush tears method. The samples were centrifuged and aliquoted into three sets of microcentrifuge tubes with each stored at 4 °C for <2 h, 4 h or 6 h (Timepoints 1, 2 or 3). After each respective storage duration, the aliquoted samples were than stored at −80 °C before analysis, within 6 months. Tears were analyzed for the concentration of substance P and the total protein content (TPC).

Results

Substance P concentrations across the three timepoints were not significantly different (p > 0.05), including Timepoint 1 (Median [interquartile range]: 10.7 ng/ml [1.6-37.9]), Timepoint 2 (10.9 ng/ml [1.6-32.6]) and Timepoint 3 (5.2 ng/ml [1.3-25.2]). There were also no significant differences in TPC concentrations measured at the three timepoints, including Timepoint 1 (3.1 mg/ml [1.7-3.8]), Timepoint 2 (2.9 mg/ml [1.9-4.1]) and Timepoint 3 (2.7 mg/ml [1.6-3.7]).

Conclusions

While the levels of substance P were stable while stored at 4 °C prior to proper −80 °C storage and analysis, future research should investigate the impact of other storage conditions such as ambient room temperature to optimize the feasibility of using tears for biomarker purposes in clinical settings.

Acknowledgements

We would like to thank Dr Thomas John Naduvilath for his statistical guidance for this manuscript.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

The data that support the findings of this study are available from the corresponding author (JCBC) upon reasonable request.

Additional information

Funding

JCBC is supported by an Australian Government Research Training Program Scholarship.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.